Impact of Preoperative Serum Albumin Level on Postoperative Outcomes in Chinese HCC Patients Treated With Surgery

NCT05970159 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 480

Last updated 2023-08-03

No results posted yet for this study

Summary

This is an observational and retrospective cohort study to evaluate the impact of the preoperative serum albumin concentration on postoperative outcomes among hepatocellular carcinoma (HCC) patients who received hepatectomy or liver transplantation.

Conditions

Sponsors & Collaborators

  • Takeda

    collaborator INDUSTRY
  • Shanghai Zhongshan Hospital

    lead OTHER

Principal Investigators

  • Huichuan Sun · Fudan University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-31
Primary Completion
2024-06-30
Completion
2025-03-31

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05970159 on ClinicalTrials.gov